As such, intratumor delivery of CCL5 mRNA with LNPs was shown to significantly reduce tumor growth, and IL-27 was found to induce robust CCL5 production by T cells resulting in antitumor activity [93]. The gene discussed is CCL5; the disease is neoplasm.